# Molecular Dynamics Simulation of Passive Diffusion across a Human Breast Cancer Cell Membrane Model. Comparison between Cisplatin and Its Pt(IV) Derivatives

**Authors:** Daniele Belletto, Stefano Scoditti, Stefano Borocci, Nico Sanna, Costantino Zazza, Emilia Sicilia

PMC · DOI: 10.1021/acs.jcim.5c02819 · 2026-03-06

## TL;DR

This study uses simulations to compare how cisplatin and its Pt(IV) derivatives pass through breast cancer cell membranes, aiming to understand their effectiveness as cancer drugs.

## Contribution

The paper introduces a comparative MD simulation study of Pt(II) and Pt(IV) complex diffusion in a human breast cancer cell membrane model.

## Key findings

- Pt(IV) complexes show different membrane permeation behavior compared to Pt(II) complexes.
- Membrane penetration differences may influence the efficacy of platinum-based anticancer drugs.
- Axial ligand release in Pt(IV) complexes could affect their activity as multiaction agents.

## Abstract

The efficacy of platinum­(II) drugs, despite their wide
use in clinical
practice, is seriously limited by their well-known drawbacks. Octahedral
Pt­(IV) congeners are considered a sort of Holy Grail in cancer research
as, being significantly more inert, they should be able to overcome
the limitations of current platinum-based drugs, such as resistance
and side effects, acting as prodrugs. Additionally, their anticancer
activity can be tuned through a proper choice of the axial ligands
released inside cancer cells when these compounds are reduced, making
them even capable of potentially working as multiaction agents. However,
despite their very satisfactory anticancer effects, no Pt­(IV) complex
has been approved for clinical use. As cell membrane permeation is
the critical step, very poorly understood, of the whole mechanism
of action of any drug, the investigation of the eventual differences
in behavior between four-coordinate Pt­(II) and six-coordinate Pt­(IV)
complexes when they diffuse in a lipid bilayer might be of significant
relevance. The outcomes of a biased molecular dynamics (MD) investigation
of the permeation of cisplatin and three simple cisplatin Pt­(IV) derivatives
through a membrane model prototype of human breast cancer cells are
illustrated here. This comparative analysis of Pt­(II) and Pt­(IV) complex
passive diffusion has been carried out with the aim of gaining indications
about the factors that play a role in favoring or hindering membrane
penetration and, ultimately, in determining the efficacy of their
anticancer action.

## Linked entities

- **Chemicals:** cisplatin (PubChem CID 5460033)
- **Diseases:** breast cancer (MONDO:0004989)

## Full-text entities

- **Diseases:** Breast Cancer (MESH:D001943), cancer (MESH:D009369)
- **Chemicals:** Pt(II) (-), Cisplatin (MESH:D002945), lipid (MESH:D008055), platinum (MESH:D010984)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

15 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13014451/full.md

---
Source: https://tomesphere.com/paper/PMC13014451